Binding Site provides specialist diagnostic products to clinicians and laboratory professionals worldwide.
The company research, develop, manufacture and distribute specialist immunodiagnostic assays and instrumentation.
The company has developed Freelite. It is a quantitative measure of serum kappa and lambda free light chains (FLCs) and can be used in initial testing, monitoring and prognosis of patients with suspected monoclonal gammopathies.
Also, Hevylite is a special test that allows improved monitoring of Multiple Myeloma patients by more accurate measurement of intact immunoglobulin monoclonal proteins. It is a set of unique laboratory serum tests which overcome some of the problems found using electrophoretic methods, especially when monitoring IgA Multiple Myeloma.